Source: Drug Discovery & Development

Verseon: For sparse data classification, VersAI's Extreme AutoML is orders of magnitude faster than Google's AutoML

A new AI technology known as VersAI, a proprietary AI technology from Verseon, is challenging the dominance of deep learning-especially in areas where data is scarce. In a recent preprint, Verseon researchers and a colleague at the University of Missouri show that VersAI can train predictive models considerably faster than Google AutoML, based on benchmark test...The post For sparse data classification, VersAI's Extreme AutoML is orders of magnitude faster than Google's AutoML appeared first on Drug Discovery and Development.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Adityo Prakash's photo - CEO of Verseon

CEO

Adityo Prakash

CEO Approval Rating

- -/100